Please login to the form below
predictive biomarkers
This page shows the latest predictive biomarkers news and features for those working in and with pharma, biotech and healthcare.
Biotech now vital to pipelines – but success rates falling
Over the next five years, IQVIA predicts that improvements in trial productivity will be driven by a handful of key trends such as biomarkers, pre-screened patient pools and predictive analytics.
Latest news
-
Janssen’s quest to prevent diseases taking hold
developed. “It will take time,” he adds. “But we can already identify children with a high risk of type 1 diabetes from certain antibodies, and there are extremely predictive biomarkers moving ... If you pick up the right biomarkers we can deal
-
Novartis boosts cardiovascular pipeline with $1bn Ionis deal
The importance of predictive biomarkers in achieving successful cardiovascular outcomes will also be essential in the future payer environment," said the company's chief medical officer Vasant Narasimhan.
-
Roche teams up with Californian university
This collaboration is an innovative approach to working closely with leading institutes, such as UCLA, at an early stage of research in the pursuit of new predictive biomarkers.". ... Under the agreement, Roche will also provide UCLA with advanced reagent
-
Slow progress
Aside from the scientific hurdles of finding and validating sufficiently predictive biomarkers, it requires close collaboration with so many players, including pharma, companion diagnostics/theranostics companies, contract research organisations,
-
Need for speed
Predictive biomarkers, that forecast the likelihood of response to a particular molecule, are now being used. ... During drug development and clinical trials, biomarkers can determine drug efficacy better with fewer patients as well as providing early
More from news
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest Intelligence
-
Encouraging signs in biomarker R&D
Immunotherapies. The challenge now is to use predictive biomarkers for non-targeted therapies, particularly in areas like immuno-oncology where determining likely response to treatment is crucial. ... It is clear that in order to [avoid] treating
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Use of biomarkers in marketing
Biomarkers are being used to determine a person’s genetic predisposition to respond well to certain treatments; these are predictive biomarkers. ... Biomarkers influence regulatory positioning and can determine, to an extent, the placement of a product
-
Top 7 Trends in Pharma Marketing for 2015
Patient Empowerment. Wearable Technology. Virtual Reality. Storytelling. Using biomarkers. Marketing and Medical Automation. ... Predictive biomarkers are being used to determine a person’s genetic predisposition to respond well to certain treatments.
More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Account Director
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Medical Editor
-
Competitive
- GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours
- Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- Sinovac’s COVID-19 vaccine appears safe in older adults
- New study identifies drugs that are safe to use in COVID-19 treatment
- Pfizer/BioNTech's COVID-19 vaccine found to be effective against UK virus variant
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
11 London
11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
